We’ve recently updated our valuation analysis.

Trinseo Valuation

Is TSE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for TSE?

Other financial metrics that can be useful for relative valuation.

TSE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.6x
Enterprise Value/EBITDA9.6x
PEG Ration/a

Price to Sales Ratio vs Peers

How does TSE's PS Ratio compare to its peers?

The above table shows the PS ratio for TSE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average0.7x
HWKN Hawkins
0.9x-4.6%US$804.6m
WLKP Westlake Chemical Partners
0.6x-2.7%US$910.5m
ASIX AdvanSix
0.6x-4.3%US$1.2b
OEC Orion Engineered Carbons
0.6x6.1%US$1.2b
TSE Trinseo
0.2x-3.0%US$925.8m

Price-To-Sales vs Peers: TSE is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (0.7x).


Price to Earnings Ratio vs Industry

How does TSE's PE Ratio compare vs other companies in the US Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.9%
n/an/an/a

Price-To-Sales vs Industry: TSE is good value based on its Price-To-Sales Ratio (0.2x) compared to the US Chemicals industry average (1.3x)


Price to Sales Ratio vs Fair Ratio

What is TSE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

TSE PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: TSE is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).


Share Price vs Fair Value

What is the Fair Price of TSE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: TSE ($26.47) is trading below our estimate of fair value ($91.62)

Significantly Below Fair Value: TSE is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst TSE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$26.47
US$27.29
+3.1%
23.9%US$40.00US$20.00n/a7
Jan ’24US$22.71
US$26.14
+15.1%
23.6%US$40.00US$20.00n/a7
Dec ’23US$24.67
US$26.14
+6.0%
23.6%US$40.00US$20.00n/a7
Nov ’23US$20.20
US$24.71
+22.3%
27.2%US$40.00US$20.00n/a7
Oct ’23US$18.32
US$33.43
+82.5%
25.8%US$48.00US$22.00n/a7
Sep ’23US$26.48
US$41.43
+56.5%
30.4%US$70.00US$33.00n/a7
Aug ’23US$35.33
US$50.14
+41.9%
18.6%US$70.00US$42.00n/a7
Jul ’23US$38.77
US$54.29
+40.0%
12.6%US$70.00US$47.00n/a7
Jun ’23US$47.26
US$58.71
+24.2%
16.4%US$70.00US$47.00n/a7
May ’23US$47.45
US$65.57
+38.2%
18.2%US$91.00US$53.00n/a7
Apr ’23US$48.02
US$67.00
+39.5%
16.3%US$91.00US$55.00n/a7
Mar ’23US$47.97
US$66.14
+37.9%
18.6%US$91.00US$51.00n/a7
Feb ’23US$55.01
US$65.43
+18.9%
19.4%US$91.00US$50.00n/a7
Jan ’23US$52.46
US$67.14
+28.0%
18.0%US$91.00US$49.00US$22.717
Dec ’22US$46.79
US$67.14
+43.5%
18.0%US$91.00US$49.00US$24.677
Nov ’22US$56.80
US$67.00
+18.0%
17.9%US$91.00US$53.00US$20.206
Oct ’22US$57.29
US$66.17
+15.5%
19.2%US$91.00US$51.00US$18.326
Sep ’22US$52.10
US$69.50
+33.4%
22.4%US$91.00US$51.00US$26.486
Aug ’22US$54.36
US$71.67
+31.8%
19.1%US$91.00US$57.00US$35.336
Jul ’22US$58.67
US$72.67
+23.9%
18.3%US$91.00US$57.00US$38.776
Jun ’22US$67.92
US$72.67
+7.0%
18.3%US$91.00US$57.00US$47.266
May ’22US$61.91
US$65.83
+6.3%
24.8%US$91.00US$40.00US$47.456
Apr ’22US$64.88
US$64.17
-1.1%
26.3%US$91.00US$40.00US$48.026
Mar ’22US$69.39
US$56.33
-18.8%
14.2%US$64.00US$40.00US$47.976
Feb ’22US$53.42
US$49.50
-7.3%
14.6%US$60.00US$40.00US$55.016
Jan ’22US$51.21
US$45.33
-11.5%
18.8%US$60.00US$37.00US$52.466

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies